Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 18 de 18
Filter
1.
J Fr Ophtalmol ; 46(2): 101-105, 2023 Feb.
Article in English | MEDLINE | ID: mdl-36635207

ABSTRACT

INTRODUCTION: The prevalence of ocular conveyance of SARS-CoV-2 has been well described for severe/hospitalized cases, but scarcely reported in asymptomatic and non-severe patients, who are unaware that they are carriers. MATERIAL & METHODS: This prospective cross-sectional study quantitatively evaluated SARS-CoV-2 shedding on the ocular surface (OS). Conjunctival testing was suggested to all hospital personnel being screened by nasopharyngeal (NP) SARS-CoV-2 reverse transcription polymerase chain reaction (RT-PCR). Disease symptoms were evaluated using a standardized questionnaire and telephone follow-up 6±3 months later for disease evolution (recovery with/without severe disease). RESULTS: Four hundred and eighty seven patients were included. From 46 NP SARS-CoV-2-positive subjects (cycle threshold [CT]=24.2±7.1), 13% tested positive at the OS (CT=36.4±2.8). Most SARS-CoV-2-positive subjects were symptomatic (n=40, 87%), while 6 were asymptomatic (being tested as contact cases). Systemic symptoms were not significantly different in OS-positive vs OS-negative subjects, although headache tended to be more frequent in OS-positives (83% vs 54%, P=0.06). None of the OS-positive subjects reported ocular symptoms and none developed severe disease requiring hospitalization or oxygen therapy. CONCLUSION: SARS-CoV-2 shedding at the OS may occur in asymptomatic and non-severe COVID-19 individuals (including those absent of ocular symptoms). However, the high RT-PCR CT values attained may indicate a low risk of transmissibility via this route.


Subject(s)
COVID-19 , Humans , COVID-19/complications , COVID-19/diagnosis , COVID-19/epidemiology , SARS-CoV-2 , Cross-Sectional Studies , Prospective Studies , Conjunctiva
2.
Arch Pediatr ; 29(4): 300-306, 2022 May.
Article in English | MEDLINE | ID: mdl-35288027

ABSTRACT

BACKGROUND: Plasmodium falciparum hyperparasitemia (over or equal to 10%), isolated or associated with other severity criteria, should be managed in a pediatric intensive care unit according to the French pediatric guidelines. The main objective of our study was to describe the management and course of these special cases. POPULATION AND METHODS: We conducted a retrospective study in eight French hospital facilities from January 2007 to December 2014. We reviewed the management of non-immune children aged 0-15 years, assessing the following: clinical and paraclinical data, type of care unit, treatment initiated, initial and long-term course. Data were analyzed for the whole population and for two groups according to the place of first-line management: group A (in pediatric intensive care unit), and group B (other places). RESULTS: A total of 61 children were included, 14 (23%) of whom were initially admitted to the intensive care unit (group A), all with neurological or hemodynamic disorders. Only 23 children (38%) overall received intravenous antimalarial treatment and the other patients received exclusively oral treatment. No deaths were reported. Median parasitemia was comparable in the two groups. In group B (n = 47/61, 77%), isolated hyperparasitemia, jaundice, and renal failure were predominant. The children who underwent initial intravenous treatment (n = 5/47, 11%) all progressed favorably, as did 92% of the children who received oral treatment (n = 42/47, 89%). CONCLUSION: A majority of children with Plasmodium falciparum hyperparasitemia were managed outside the pediatric intensive care unit via the oral route, against the French pediatric guidelines except when neurologic or hemodynamic disorders were present. Initial clinical evaluation and hospital supervision are essential for the best management of these patients.


Subject(s)
Antimalarials , Malaria, Falciparum , Malaria , Antimalarials/therapeutic use , Child , Humans , Malaria/epidemiology , Malaria, Falciparum/complications , Malaria, Falciparum/diagnosis , Plasmodium falciparum , Retrospective Studies
3.
J Fr Ophtalmol ; 43(10): 1069-1077, 2020 Dec.
Article in French | MEDLINE | ID: mdl-33127178

ABSTRACT

Demodex is a saprophytic mite of the ocular adnexa, which can in certain circumstances proliferate on the skin of the face and on the eyelid margins. It is involved in facial rosacea (especially in the papulopustular form) and in the development or aggravation of anterior and/or posterior blepharitis or even keratoconjunctivitis, often in association with cutaneous lesions ; the pathophysiology is often multifactorial. Symptoms are non-specific, but the presence of cylindrical sleeves on the eyelashes is very suggestive of infestation, and certain techniques of biomicroscopic examination or imaging, such as confocal microscopy in vivo, allow direct visualization of the parasite. Parasitological examination of the eyelashes can confirm the diagnosis and can be improved by good sampling technique. Eyelid hygiene and oil-based ointments are the cornerstone of treatment. New specific treatments, in particular topical treatments based on tea tree oil, ivermectin, as well as pulsed light therapy and micro-exfoliation of the eyelid margin, can help to reduce the parasitic load and improve symptoms.


Subject(s)
Eye Infections, Parasitic , Mites/physiology , Animals , Blepharitis/diagnosis , Blepharitis/drug therapy , Blepharitis/epidemiology , Eye Infections, Parasitic/diagnosis , Eye Infections, Parasitic/drug therapy , Eye Infections, Parasitic/epidemiology , Eye Infections, Parasitic/parasitology , Eyelashes/diagnostic imaging , Eyelashes/parasitology , Eyelashes/pathology , Humans , Hygiene , Ivermectin/therapeutic use , Keratoconjunctivitis/diagnosis , Keratoconjunctivitis/drug therapy , Keratoconjunctivitis/epidemiology , Keratoconjunctivitis/parasitology , Meibomian Glands/diagnostic imaging , Meibomian Glands/parasitology , Meibomian Glands/pathology , Microscopy, Confocal , Tea Tree Oil/therapeutic use
4.
J Mycol Med ; 30(2): 100970, 2020 Jun.
Article in English | MEDLINE | ID: mdl-32334948

ABSTRACT

A survey of mycology laboratories for antifungal susceptibility testing (AFST) was undertaken in France in 2018, to better understand the difference in practices between the participating centers and to identify the difficulties they may encounter as well as eventual gaps with published standards and guidelines. The survey captured information from 45 mycology laboratories in France on how they perform AFST (number of strains tested, preferred method, technical and quality aspects, interpretation of the MIC values, reading and interpretation difficulties). Results indicated that 86% of respondents used Etest as AFST method, with a combination of one to seven antifungal agents tested. Most of the participating laboratories used similar technical parameters to perform their AFST method and a large majority used, as recommended, internal and external quality assessments. Almost all the participating mycology laboratories (98%) reported difficulties to interpret the MIC values, especially when no clinical breakpoints are available. The survey highlighted that the current AFST practices in France need homogenization, particularly for MIC reading and interpretation.


Subject(s)
Antifungal Agents/therapeutic use , Laboratories , Microbial Sensitivity Tests , Mycology , Professional Practice/statistics & numerical data , Disk Diffusion Antimicrobial Tests/methods , Disk Diffusion Antimicrobial Tests/standards , Disk Diffusion Antimicrobial Tests/statistics & numerical data , Drug Resistance, Fungal , France , History, 21st Century , Humans , Laboratories/standards , Laboratories/statistics & numerical data , Laboratory Proficiency Testing/methods , Laboratory Proficiency Testing/statistics & numerical data , Microbial Sensitivity Tests/methods , Microbial Sensitivity Tests/standards , Microbial Sensitivity Tests/statistics & numerical data , Mycology/history , Mycology/methods , Mycology/standards , Mycology/statistics & numerical data , Professional Practice/standards , Quality Control , Surveys and Questionnaires
5.
Med Mycol ; 56(6): 774-777, 2018 Aug 01.
Article in English | MEDLINE | ID: mdl-29087508

ABSTRACT

Cryptococcal antigen (CryAg) testing in serum and CSF is a clue diagnostic tool for cryptococcosis. In this study, we reviewed the performances of the CryAg detection (Premier EIA, Meridian) routinely performed in broncho-alveolar lavage fluid (BALF) during a 7-year period (2007-2013). CryAg was detected in 12 cases among 4650 BALF analyzed, while positive culture from BALF was detected in nine cases. We found sensitivity, specificity, positive and negative predictive values at 0.44-0.80 (according to the radio-clinical form), 0.99, 0.36, and 0.99, respectively. These results do not support the routine use of the test in BALF.


Subject(s)
Bronchoalveolar Lavage Fluid/microbiology , Cryptococcosis/diagnosis , Cryptococcus neoformans/immunology , Antigens, Fungal/analysis , Cryptococcosis/immunology , Cryptococcosis/microbiology , Cryptococcus neoformans/isolation & purification , Databases, Factual , Humans , Latex Fixation Tests , Predictive Value of Tests
6.
Antimicrob Agents Chemother ; 60(8): 5088-91, 2016 08.
Article in English | MEDLINE | ID: mdl-27297480

ABSTRACT

In vitro susceptibility of 933 Candida isolates, from 16 French hospitals, to micafungin was determined using the Etest in each center. All isolates were then sent to a single center for determination of MICs by the EUCAST reference method. Overall essential agreement between the two tests was 98.5% at ±2 log2 dilutions and 90.2% at ±1 log2 dilutions. Categorical agreement was 98.2%. The Etest is a valuable alternative to EUCAST for the routine determination of micafungin MICs in medical mycology laboratories.


Subject(s)
Antifungal Agents/pharmacology , Candida/drug effects , Echinocandins/pharmacology , Lipopeptides/pharmacology , Candida/genetics , Drug Resistance, Fungal/genetics , Micafungin , Microbial Sensitivity Tests
7.
FEMS Yeast Res ; 16(2): fov114, 2016 Mar.
Article in English | MEDLINE | ID: mdl-26691882

ABSTRACT

During the previous decades, as the number of immunocompromised patients, the average age of Western populations and the widespread use of indwelling medical devices have increased concomitantly, so has the incidence of infections caused by Candida species. Candida albicans remains the most frequently isolated agent of candidiasis. However, C. glabrata now accounts for a substantial part of clinical isolates, ranking number two among the etiologic agents of either superficial or invasive candidiasis in North America and Europe. Along with C. glabrata and belonging to the Nakaseomyces clade, two new species, C. nivariensis and C bracarensis have recently been described as emerging pathogens. This review provides information on the current state of knowledge on the epidemiology, biology, identification, pathogenicity and antifungal resistance of C. glabrata, C. nivariensis and C. bracarensis.


Subject(s)
Antifungal Agents/pharmacology , Candida/classification , Candida/isolation & purification , Candidiasis/epidemiology , Candidiasis/microbiology , Drug Resistance, Fungal , Candida/drug effects , Candida/physiology , Communicable Diseases, Emerging/epidemiology , Communicable Diseases, Emerging/microbiology , Global Health , Humans , Virulence Factors/genetics
8.
J Clin Microbiol ; 53(5): 1655-61, 2015 May.
Article in English | MEDLINE | ID: mdl-25762773

ABSTRACT

Candida inconspicua and Candida (Pichia) norvegensis are two emerging pathogenic species that exhibit reduced susceptibility to azole derivatives. Conventional (biochemical) approaches do not readily differentiate between the two species. The first aim of this work was to analyze the performance of biochemical, proteomic (matrix-assisted laser desorption ionization-time of flight [MALDI-TOF]), and molecular approaches in the precise identification of these species. These results then led us to sequence 3 genomic loci, i.e., the internal transcribed spacer (ITS) region of the ribosomal DNA (rDNA), the D1/D2 domain of the 28S rDNA, and the elongation factor 1α (EF-1α) gene, either directly or following cloning, of 13 clinical isolates and 9 reference strains belonging to the 5 species included in the Pichia cactophila clade, namely, Pichia cactophila, Pichia insulana, C. inconspicua, C. norvegensis, and P. pseudocactophila. Finally, isolates of C. inconspicua were challenged for sexual reproduction on the appropriate medium. Our results show that EF-1α sequencing and proteic profiling by MALDI-TOF are the two most efficient approaches to distinguish between C. norvegensis and C. inconspicua. As a characteristic of the P. cactophila clade, we found multiple alleles of the rDNA regions in certain strains belonging to the tested species, making ITS or D1/D2 sequencing not appropriate for identification. Whatever the method of identification, including MALDI-TOF and EF-1α sequencing, none could differentiate C. inconspicua from P. cactophila. The results of phylogenetic analysis and the generation of asci from pure cultures of all C. inconspicua strains both support the identification of P. cactophila as the teleomorph of C. inconspicua.


Subject(s)
Candida/classification , Crosses, Genetic , Gene Order , Candida/chemistry , Candida/genetics , Candida/metabolism , Candidiasis/microbiology , Cluster Analysis , DNA, Fungal/chemistry , DNA, Fungal/genetics , DNA, Ribosomal/chemistry , DNA, Ribosomal/genetics , DNA, Ribosomal Spacer/chemistry , DNA, Ribosomal Spacer/genetics , Humans , Molecular Sequence Data , Mycological Typing Techniques , Peptide Elongation Factor 1/genetics , Phylogeny , Proteome/analysis , RNA, Ribosomal, 28S/genetics , Sequence Analysis, DNA , Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization
9.
Int J Antimicrob Agents ; 43(6): 566-9, 2014 Jun.
Article in English | MEDLINE | ID: mdl-24787480

ABSTRACT

Amphotericin B is a powerful polyene antifungal drug used for treating systemic fungal infections and is usually administered for a short period. Side effects after prolonged use are unknown in humans. Here we report the case of a 28-year-old man suffering from chronic granulomatous disease (CGD), treated for invasive cerebral aspergillosis with liposomal amphotericin B (L-AmB) for a very long time (8 consecutive years). We describe the efficacy and safety of this treatment in the long term. Aspergillosis was kept under control as long as L-AmB therapy was maintained, but relapsed when the dose was reduced. No overt renal toxicity was noted. The patient gradually developed hepatosplenomegaly and pancytopenia. Abnormalities of bone marrow were similar to the sea-blue histiocyte syndrome. Liver biopsy showed images of nodular regenerative hyperplasia related to CGD as well as a histiocytic storage disease. We discuss the very prolonged use of L-AmB leading to the development of a lysosomal storage disease.


Subject(s)
Amphotericin B/adverse effects , Amphotericin B/therapeutic use , Antifungal Agents/adverse effects , Antifungal Agents/therapeutic use , Lysosomal Storage Diseases/chemically induced , Adult , Biopsy , Granulomatous Disease, Chronic/complications , Histocytochemistry , Humans , Liver/pathology , Male , Neuroaspergillosis/drug therapy
10.
Clin Microbiol Infect ; 20(8): 784-90, 2014 Aug.
Article in English | MEDLINE | ID: mdl-24355037

ABSTRACT

Trichosporon spp. have recently emerged as significant human pathogens. Identification of these species is important, both for epidemiological purposes and for therapeutic management, but conventional identification based on biochemical traits is hindered by the lack of updates to the species databases provided by the different commercial systems. In this study, 93 strains, or isolates, belonging to 16 Trichosporon species were subjected to both molecular identification using IGS1 gene sequencing and matrix-assisted laser desorption ionisation-time-of-flight (MALDI-TOF) analysis. Our results confirmed the limits of biochemical systems for identifying Trichosporon species, because only 27 (36%) of the isolates were correctly identified using them. Different protein extraction procedures were evaluated, revealing that incubation for 30 min with 70% formic acid yields the spectra with the highest scores. Among the six different reference spectra databases that were tested, a specific one composed of 18 reference strains plus seven clinical isolates allowed the correct identification of 67 of the 68 clinical isolates (98.5%). Although until recently it has been less widely applied to the basidiomycetous fungi, MALDI-TOF appears to be a valuable tool for identifying clinical Trichosporon isolates at the species level.


Subject(s)
Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization/methods , Trichosporon/chemistry , Trichosporon/classification , Trichosporonosis/diagnosis , Trichosporonosis/microbiology , Fungal Proteins/chemistry , Fungal Proteins/isolation & purification , Humans , Sensitivity and Specificity , Specimen Handling/methods , Trichosporon/isolation & purification
12.
Eur J Clin Microbiol Infect Dis ; 30(5): 673-5, 2011 May.
Article in English | MEDLINE | ID: mdl-21229281

ABSTRACT

The aims of this network group were to collect epidemiological data of PcP cases in 14 hospitals in the Paris area and to determine the Di-Hydro Pteroate Synthase (DHPS) genotypes, genetic markers for possible sulfamide resistance. From January 1, 2003 to December 31, 2008, 993 (mean 166/year) PcP cases have been reported. Sixty-five percent of patients were HIV-positive. The median count of CD4 lymphocytes was 32/mm(3) (30 in HIV-positive patients, 152 in HIV-negative patients). In HIV-positive patients, PcP revealed the HIV infection in 39%. Among 304 PcP occurring in HIV known infected patients, no prophylaxis was prescribed for 64%; cotrimoxazole prophylaxis had been prescribed to 47 patients but only one of them had the right compliance. In HIV-negative patients (264), corticosteroids were prescribed in 59% and cytotoxic chemotherapies in 34%; 78% did not receive prophylaxis. One hundred sixty nine tumoral pathologies and 116 transplantations were notified. The mortality rate was 16% at day 14 (13% in HIV-positive patients, 26% in HIV-negative patients). Mutations in DHPS genes were detected in 18.5% of samples; 12.5% of patients were infected with several strains. The total annual number of cases has been stable for five years but the proportion of HIV-negative patients increased from 25% to 43%.


Subject(s)
Pneumocystis carinii/isolation & purification , Pneumonia, Pneumocystis/epidemiology , Adrenal Cortex Hormones/administration & dosage , Antifungal Agents/pharmacology , Antineoplastic Agents/administration & dosage , CD4 Lymphocyte Count , Comorbidity , Dihydropteroate Synthase/genetics , Drug Resistance, Fungal , Female , Genotype , HIV Infections/drug therapy , HIV Infections/epidemiology , Hospitals , Humans , Immunocompromised Host , Male , Middle Aged , Neoplasms/drug therapy , Neoplasms/epidemiology , Paris/epidemiology , Pneumocystis carinii/classification , Pneumocystis carinii/drug effects , Pneumocystis carinii/genetics , Pneumonia, Pneumocystis/microbiology , Sulfanilamides/pharmacology , Transplantation
13.
J Clin Microbiol ; 48(11): 4028-34, 2010 Nov.
Article in English | MEDLINE | ID: mdl-20844221

ABSTRACT

Candida glabrata has emerged as the second most common etiologic agent, after Candida albicans, of superficial and invasive candidiasis in adults. Strain typing is essential for epidemiological investigation, but easy-to-use and reliable typing methods are still lacking. We report the use of a multilocus microsatellite typing method with a set of eight markers on a panel of 180 strains, including 136 blood isolates from hospitalized patients and 34 digestive tract isolates from nonhospitalized patients. A total of 44 different alleles were observed, generating 87 distinct genotypes. In addition to perfect reproducibility, typing ability, and stability, the method had a discriminatory power calculated at 0.97 when all 8 markers were associated, making it suitable for tracing strains. In addition, it is shown that digestive tract isolates differed from blood culture isolates by exhibiting a higher genotypic diversity associated with different allelic frequencies and preferentially did not group in clonal complexes (CCs). The demonstration of the occurrence of microevolution in digestive strains supports the idea that C. glabrata can be a persistent commensal of the human gut.


Subject(s)
Candida glabrata/classification , Candida glabrata/genetics , Candidiasis/microbiology , Digestive System/microbiology , Fungemia/microbiology , Microsatellite Repeats , Mycological Typing Techniques/methods , Adult , DNA, Fungal/genetics , Genetic Variation , Genotype , Humans , Molecular Epidemiology/methods , Reproducibility of Results , Sensitivity and Specificity
14.
Med Trop (Mars) ; 67(2): 145-8, 2007 Apr.
Article in French | MEDLINE | ID: mdl-17691432

ABSTRACT

In the Democratic Republic of Congo (DRC), as in many African countries, AIDS and its procession of opportunistic infections are a major cause of morbidity and mortality. In Kinshasa, the estimated prevalence rate of HIV-infected persons is between 4 and 5%, corresponding to more than 200,000 people. Due to the lack of trained laboratory personnel and appropriate diagnostic equipment, no local investigation has been carried out to determine the prevalence of the opportunistic digestive parasitic infection in HIV-infected persons. As a step to obtaining this information that is needed for implementation of an adequate care policy, a preliminary investigation was carried out in Paris, France on 50 stool samples from 50 AIDS-patients hospitalized in 3 reference hospitals in Kinshasa. Eleven patients (22%) had digestive symptoms with a diarrhea syndrome. Further study using specialized techniques demonstrated 2 cases of digestive infection related to opportunistic parasites (4%). The first involved a Cryptosporidium sp. The second represented the first case of Enterocytozoon bieneusi infection reported in the literature from the DRC.


Subject(s)
AIDS-Related Opportunistic Infections/epidemiology , Intestinal Diseases, Parasitic/epidemiology , AIDS-Related Opportunistic Infections/parasitology , Adult , Democratic Republic of the Congo/epidemiology , Diarrhea/parasitology , Female , Humans , Intestinal Diseases, Parasitic/parasitology , Male , Middle Aged , Prevalence
15.
J Clin Microbiol ; 45(4): 1261-5, 2007 Apr.
Article in English | MEDLINE | ID: mdl-17287323

ABSTRACT

Cryptococcus neoformans is a fungal pathogen that causes life-threatening infections primarily in immunocompromised hosts. Based on the genetic characteristics and serologic properties of capsular polysaccharides, three varieties and five serotypes have been defined: C. neoformans var. neoformans (serotype D), C. neoformans var. grubii (serotype A), hybrid serotype AD, and C. neoformans var. gattii (serotypes B and C). Epidemiologic features, such as geographic distribution and ecologic niche, and clinical characteristics have been shown to be associated with serotypes. At the present time, serotyping is based on agglutination tests with either commercial or "homemade" antisera or on immunofluorescence assays using a monoclonal antibody directed against the capsule polysaccharide. In this paper, we describe two molecular methods (PCR-restriction enzyme analysis and length polymorphism analysis) for C. neoformans serotype identification. Both are based on the sequence characteristics of a fragment of the CAP59 gene required for capsule biosynthesis. Testing of 72 C. neoformans strains including representatives of the five serotypes demonstrated the reliability of these methods.


Subject(s)
Cryptococcus neoformans/classification , Cryptococcus neoformans/genetics , Polymerase Chain Reaction/methods , Polymorphism, Restriction Fragment Length , Cryptococcosis/microbiology , Cryptococcus neoformans/immunology , DNA, Fungal/genetics , Fungal Proteins/genetics , Humans , Sensitivity and Specificity , Serotyping
16.
Médecine Tropicale ; 67(2): 145-148, 2007. tables
Article in French | AIM (Africa) | ID: biblio-1266759

ABSTRACT

En Republique Democratique du Congo (RDC); comme dans de nombreux pays africains; le sida et son cortege d'infections opportunistes sont une cause majeure de morbidite et de mortalite. A Kinshasa; on estime entre 4 et 5le taux de prevalence de sujets infectes par le VIH; soit plus de 200 000 personnes (chiffres du Programme National de Lutte contre le Sida; PNLS 2005). A ce jour; faute de personnels formes et de moyens diagnostiques adaptes; aucune enquete n'a encore ete menee sur la prevalence des parasites opportunistes digestifs dans la population des patients infectes par leVIH; prealable indispensable a la mise en place d'une politique de soin adaptee. Une enquete preliminaire a ete realisee a Paris sur 50 echantillons de selles de 50 patients malades du sida; hospitalises dans 3 hopitaux de references de Kinshasa. Onze patients (22) avaient une symptomatologie digestive avec un syndrome diarrheique. La realisation des examens specialises a mis en evidence 2 cas d'infection digestive par des parasitoses opportunistes (4); une a Cryptosporidium sp. et une a Enterocytozoon bieneusi; premier cas decrit dans la litterature en RDC


Subject(s)
Humans , AIDS-Related Opportunistic Infections/epidemiology , Cryptosporidium , Enterocytozoon , Acquired Immunodeficiency Syndrome , HIV , Microsporidia
17.
Médecine Tropicale ; 67(2): 145-148, 2007. tables
Article in French | AIM (Africa) | ID: biblio-1266764

ABSTRACT

En Republique Democratique du Congo (RDC); comme dans de nombreux pays africains; le sida et son cortege d'infections opportunistes sont une cause majeure de morbidite et de mortalite. A Kinshasa; on estime entre 4 et 5le taux de prevalence de sujets infectes par le VIH; soit plus de 200 000 personnes (chiffres du Programme National de Lutte contre le Sida; PNLS 2005).A ce jour; faute de personnels formes et de moyens diagnostiques adaptes; aucune enquete n'a encore ete menee sur la prevalence des parasites opportunistes digestifs dans la population des patients infectes par leVIH; prealable indispensable a la mise en place d'une politique de soin adaptee. Une enquete preliminaire a ete realisee a Paris sur 50 echantillons de selles de 50 patients malades du sida; hospitalises dans 3 hopitaux de references de Kinshasa. Onze patients (22) avaient une symptomatologie digestive avec un syndrome diarrheique. La realisation des examens specialises a mis en evidence 2 cas d'infection digestive par des parasitoses opportunistes (4); une a Cryptosporidium sp. et une a Enterocytozoon bieneusi; premier cas decrit dans la litterature en RDC


Subject(s)
Enterocytozoon
18.
Clin Microbiol Infect ; 12(7): 674-6, 2006 Jul.
Article in English | MEDLINE | ID: mdl-16774566

ABSTRACT

A cluster of cases of Candida albicans candidaemia in a surgical intensive care unit was investigated. The probability of such a cluster during a single month was highly significant compared with the frequency of candidaemia in the previous year. A molecular typing method, based on length analysis of three (EF3, CDC3, HIS3) microsatellite-containing regions, was used to investigate isolates from patients in and outside the ward. This demonstrated the involvement of different strains, indicating the absence of cross-transmission among patients. Results of microsatellite typing can be obtained almost in real-time, which is particularly useful in an outbreak context.


Subject(s)
Candida albicans/isolation & purification , Candidiasis/diagnosis , Cross Infection/diagnosis , Disease Outbreaks , Aged , Candida albicans/genetics , Candidiasis/blood , Cross Infection/blood , Humans , Intensive Care Units , Male , Microsatellite Repeats/genetics , Middle Aged , Poisson Distribution
SELECTION OF CITATIONS
SEARCH DETAIL
...